Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis [Phase 2]

View source ↗

Summary

A Phase 2 trial tested whether azithromycin can prevent wheezing after severe RSV bronchiolitis; the study has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: RSV Bronchiolitis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14